Kalydeco (ivacaftor) by Vertex Pharmaceuticals has been approved in the European Union for children ages 1-2 with cystic fibrosis (CF) who…
Articles by Patricia Inácio, PhD
Rice University researchers are using a virus that infects moths and magnetic nanoparticles to develop a new vehicle for…
Synspira’s inhaled SNSP113 candidate therapy against bacterial biofilms in the lungs of patients with cystic fibrosis (CF) has received orphan drug…
Adding bicarbonate, a salt, to the culture medium of Pseudomonas aeruginosa and Staphylococcus aureus, two of the most common…
Cystic fibrosis patients who failed to show early improvements in lung function while being treated with Orkambi (lumacaftor/ivacaftor)…
Up to one month of treatment with inhaled vancomycin, the antibiotic of choice for treating most methicillin-resistant Staphylococcus aureus (MRSA) infections, together with…
Single nucleotide polimorphisms (or variants), known as SNPs — the most common type of genetic variation — in the SLC26A9 gene are linked…
A study in mice showed it is possible to transplant stem cells into the lungs and replenish the airways with…
A previously undiscovered and rare type of cell has been identified in the tissue lining the airway of the lungs…
Combining the approved multiple sclerosis treatment glatiramer acetate with the antibiotic tobramycin improved its ability to kill antibiotic-resistant strains of Pseudomonas aeruginosa isolated from…